Cargando…
Ligand-centred redox activation of inert organoiridium anticancer catalysts
Organometallic complexes with novel activation mechanisms are attractive anticancer drug candidates. Here, we show that half-sandwich iodido cyclopentadienyl iridium(iii) azopyridine complexes exhibit potent antiproliferative activity towards cancer cells, in most cases more potent than cisplatin. D...
Autores principales: | Zhang, Wen-Ying, Banerjee, Samya, Hughes, George M., Bridgewater, Hannah E., Song, Ji-Inn, Breeze, Ben G., Clarkson, Guy J., Coverdale, James P. C., Sanchez-Cano, Carlos, Ponte, Fortuna, Sicilia, Emilia, Sadler, Peter J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8159363/ https://www.ncbi.nlm.nih.gov/pubmed/34094073 http://dx.doi.org/10.1039/d0sc00897d |
Ejemplares similares
-
Organoiridium Complexes: Anticancer Agents and Catalysts
por: Liu, Zhe, et al.
Publicado: (2014) -
The Potent Oxidant Anticancer Activity of Organoiridium Catalysts**
por: Liu, Zhe, et al.
Publicado: (2014) -
Nucleus‐Targeted Organoiridium–Albumin Conjugate for Photodynamic Cancer Therapy
por: Zhang, Pingyu, et al.
Publicado: (2019) -
Reduction of Quinones by NADH Catalyzed by Organoiridium Complexes**
por: Liu, Zhe, et al.
Publicado: (2013) -
Organoiridium Photosensitizers Induce Specific Oxidative Attack on Proteins within Cancer Cells
por: Zhang, Pingyu, et al.
Publicado: (2017)